Indication

Hyperprolactinemia

Hyperprolactinemia is an endocrine disorder characterized by abnormally elevated circulating levels of prolactin, a polypeptide hormone synthesized and secreted by the anterior pituitary gland. Read more about Hyperprolactinemia

28 drugs 24 manufacturers

Advertisement

Drugs that treat it

Common Hyperprolactinemia therapies.

Showing 10–18 of 28 drugs

CABERGOLINE

ANTIPARKINSONIAN DOPAMINE AGONISTS·HYPERPROLACTINEMIA
Mylan Pharmaceuticals
Filter & compare in the drug finder →Opens the drug finder with Hyperprolactinemia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Hyperprolactinemia.

Hyperprolactinemia is an endocrine disorder characterized by abnormally elevated circulating levels of prolactin, a polypeptide hormone synthesized and secreted by the anterior pituitary gland.

Pathophysiologically, the condition commonly arises from prolactin-secreting pituitary adenomas (prolactinomas), loss of hypothalamic dopaminergic inhibition due to stalk disruption or dopamine receptor antagonist medications, primary hypothyroidism, or renal clearance impairment.

Elevated prolactin suppresses hypothalamic gonadotropin-releasing hormone pulsatility, resulting in hypogonadism and reproductive dysfunction across both sexes.

Clinical manifestations typically include galactorrhea, oligomenorrhea, amenorrhea, and infertility in females, as well as decreased libido, erectile dysfunction, gynecomastia, and subfertility in males.

Personalize your experience

Follow Hyperprolactinemia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it